Rocío Montejano - Concepedia

Author

Rocío Montejano

Also Known As

C Miralles, Daniel Camprubí, JR Arribas, Jose R Arribas, Jose R. Arribas, M.L. Martín-Carbonero, Paco López, R De Miguel Buckley, R Montejano, R. Montejano

119

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario La Paz Instituto de Salud Carlos III Centro de Investigación Biomédica en Red Hospital La Paz Institute for Health Research Inserm

About

Rocío Montejano is an author at Hospital Universitario La Paz specializing in epidemiology, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	268
2	Epidemiology	3	3	268
3	Public Health	2	2	200
4	Hospital Medicine	1	1	98
5	Immunology	1	1	68

Rocío Montejano

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 Jason D. Goldman, David Chien Lye, David S.C. Hui, New England Journal of Medicine	2020	1.4K
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial François-Xavier Lescure, Hitoshi Honda, Robert Fowler, The Lancet Respiratory Medicine	2021	246
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19) Jesús Rodríguez‐Baño, Jerónimo Pachón, Jordi Carratalà, Clinical Microbiology and Infection	2020	127
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Pilar Barrúz, The Lancet HIV Epigenetic Age AccelerationSexual HealthHiv/aids CounsellingTreatment And PreventionLongevity	2021	102
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study Belén Gutiérrez‐Gutiérrez, María Dolores del Toro, Alberto M. Borobia, The Lancet Infectious Diseases Prognostic EvaluationDisease ProgressionMulticentre Cohort StudyClinical PhenotypesClinical Epidemiology	2021	98
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron, The Lancet HIV Primary ImmunodeficiencyTreatment And PreventionHuman RetrovirusImmunologyFirst-line Antiretroviral Therapy	2020	68
Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus–Infected Recipients of Long-term Antiretroviral Treatment Andrés Esteban-Cantos, Rocío Montejano, Javier Rodríguez-Centeno, The Journal of Infectious Diseases	2021	44
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) Rosa de Miguel Buckley, David Rial‐Crestelo, Lourdes Domínguez, EBioMedicine	2020	37
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) Antonio Pérez‐Martínez, Marta Mora-Rillo, Cristina Ferreras, EClinicalMedicine	2021	36
Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV–Infected Adults Rocío Montejano, Natalia Stella-Ascariz, Susana Monge, The Journal of Infectious Diseases	2018	32

Page 1